Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Fine Organic Inds.

₹4414.1 198.2 | 4.7%

Market Cap ₹13534 Cr.

Stock P/E 32.9

P/B 7

Current Price ₹4414.1

Book Value ₹ 626.6

Face Value 5

52W High ₹5160

Dividend Yield 0.23%

52W Low ₹ 4005

Fine Organic Inds. Research see more...

Overview Inc. Year: 2002Industry: Chemicals

Fine Organic Industries Ltd manufactures, strategies, resources, distributes, and imports oleochemical-based additives in India and across the world. It offers food components, which include emulsifiers, antifungal components, and other speciality additive blends; plastic components, such as dispersing retailers, processing aids, anti-stats, glide improvers, lubricants, mildew release retailers, slip sellers, and antifogging additives for polymers, polymer compounds and masterbatches, foamed products, PVC products, and engineering plastics; cosmetics and pharmaceuticals components; coating additives; and components for different speciality application in numerous industries. The agency was founded in 1970 and is situated in Mumbai, India.

Read More..

Fine Organic Inds. Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Peer Comparison

Fine Organic Inds. Quarterly Results

#(Fig in Cr.) Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 463 617 748 919 760 597 547 540 488 547
Other Income 7 14 17 19 15 13 14 17 17 23
Total Income 470 631 764 939 775 610 562 558 506 570
Total Expenditure 384 457 533 665 599 394 406 409 370 403
Operating Profit 86 174 231 273 175 215 156 148 136 166
Interest 1 1 1 1 1 1 1 1 1 1
Depreciation 10 11 11 12 12 13 12 14 15 15
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 -1
Profit Before Tax 75 162 219 260 162 201 143 133 120 150
Provision for Tax 23 40 59 58 55 51 43 29 25 35
Profit After Tax 52 122 160 203 107 150 101 104 95 115
Adjustments 0 -0 -0 -0 -1 -1 -1 -1 -1 -0
Profit After Adjustments 52 122 160 203 106 149 100 103 94 115
Adjusted Earnings Per Share 17 39.7 52.1 66.1 34.6 48.7 32.5 33.7 30.7 37.4

Fine Organic Inds. Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 496 567 615 660 779 856 1060 1038 1133 1876 3023 2122
Other Income 2 7 2 9 4 16 24 23 17 33 64 71
Total Income 498 574 617 669 783 872 1084 1061 1150 1909 3087 2196
Total Expenditure 445 459 501 514 634 697 827 798 934 1512 2192 1588
Operating Profit 53 116 116 155 149 174 258 264 216 397 895 606
Interest 10 11 8 8 4 3 6 8 6 5 5 4
Depreciation 11 11 23 30 24 20 17 35 47 40 48 56
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 -1
Profit Before Tax 31 95 86 117 121 151 234 216 162 352 841 546
Provision for Tax 10 33 29 41 43 56 95 51 42 92 223 132
Profit After Tax 21 62 57 76 78 95 140 165 120 260 618 415
Adjustments 0 0 0 0 0 0 -3 -0 -0 -0 0 -3
Profit After Adjustments 21 62 57 76 78 95 136 165 120 260 618 412
Adjusted Earnings Per Share 7.2 21.3 19.7 26.3 26.9 31.1 44.4 53.7 39.2 84.7 201.6 134.3

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 61% 43% 29% 20%
Operating Profit CAGR 125% 50% 39% 33%
PAT CAGR 138% 55% 45% 40%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -3% 11% 26% NA%
ROE Average 49% 33% 32% 32%
ROCE Average 65% 42% 41% 37%

Fine Organic Inds. Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 98 159 194 254 328 396 500 619 731 959 1541
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 66 87 55 52 0 0 93 91 57 25 0
Other Non-Current Liabilities 1 1 -1 -3 -4 -5 4 1 -4 -7 -10
Total Current Liabilities 90 93 126 113 116 134 105 134 155 251 265
Total Liabilities 256 340 375 416 441 525 702 845 940 1228 1796
Fixed Assets 75 70 124 125 97 88 78 217 196 229 214
Other Non-Current Assets 6 76 41 40 63 103 190 104 123 110 162
Total Current Assets 175 194 210 251 281 333 434 524 620 888 1420
Total Assets 256 340 375 416 441 525 702 845 940 1228 1796

Fine Organic Inds. Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 2 8 9 3 40 14 11 108 206 259 226
Cash Flow from Operating Activities 49 2 80 114 45 65 98 219 134 67 485
Cash Flow from Investing Activities -10 -29 -65 -28 -16 -52 -93 -85 -40 -56 -85
Cash Flow from Financing Activities -33 28 -20 -56 -55 -17 92 -37 -41 -68 -69
Net Cash Inflow / Outflow 6 1 -6 30 -26 -3 97 98 53 -58 332
Closing Cash & Cash Equivalent 8 9 3 44 14 11 108 206 259 226 515

Fine Organic Inds. Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 7.21 21.31 19.69 26.29 26.87 31.09 44.43 53.74 39.24 84.67 201.6
CEPS(Rs) 11.13 24.97 27.51 36.58 35.05 37.63 51.23 65.05 54.5 97.72 217.22
DPS(Rs) 0 0 15 22.5 22.5 7 7 7 11 9 9
Book NAV/Share(Rs) 33.67 54.97 66.83 87.7 113.2 129.02 163.16 201.86 238.55 312.85 502.69
Core EBITDA Margin(%) 9.85 18.29 17.7 21.04 17.76 18.25 21.98 23.08 17.55 19.27 27.45
EBIT Margin(%) 7.96 17.7 14.49 18.05 15.34 17.78 22.6 21.51 14.82 18.84 27.93
Pre Tax Margin(%) 5.95 15.93 13.3 16.85 14.81 17.41 22.03 20.74 14.28 18.58 27.78
PAT Margin (%) 4.02 10.4 8.86 10.99 9.54 10.98 13.14 15.82 10.6 13.73 20.42
Cash Profit Margin (%) 6.2 12.19 12.38 15.29 12.45 13.29 14.78 19.14 14.72 15.84 22
ROA(%) 8.17 20.72 15.97 19.28 18.18 19.74 22.75 21.3 13.48 23.96 40.88
ROE(%) 21.42 48.07 32.34 34.03 26.75 26.35 31.17 29.45 17.82 30.72 49.44
ROCE(%) 20.06 43.98 32.87 38.33 34.53 37.75 44.57 32.67 21.52 38.78 65.39
Receivable days 39.12 40.65 46.98 46.84 44.54 54 51.88 50.43 47.24 44.67 39.3
Inventory Days 43.28 35.65 33.66 37.02 37.66 38.11 30.64 38.7 41.44 34.9 41.03
Payable days 43.91 53.34 54.85 51.77 44.21 45.19 35.82 43.41 47.86 39.94 34.62
PER(x) 0 0 0 0 0 0 27.83 35.39 58.17 47.41 21.36
Price/Book(x) 0 0 0 0 0 0 7.58 9.42 9.57 12.83 8.57
Dividend Yield(%) 0 0 0 0 0 0 0.57 0.37 0.48 0.22 0.21
EV/Net Sales(x) 0.21 0.19 0.17 0.1 0.03 0.07 3.59 5.53 6.02 6.47 4.2
EV/Core EBITDA(x) 2.01 0.93 0.9 0.41 0.18 0.32 14.79 21.78 31.54 30.54 14.2
Net Sales Growth(%) 0 14.25 8.38 7.32 18.1 9.84 23.9 -2.1 9.16 65.57 61.12
EBIT Growth(%) 0 153.71 -11.21 34.09 0.04 23.29 55.62 -6.7 -24.91 111.83 137.21
PAT Growth(%) 0 195.48 -7.56 33.49 2.21 22.41 46.45 18.05 -26.98 115.81 138
EPS Growth(%) 0 195.48 -7.56 33.49 2.21 15.71 42.9 20.96 -26.98 115.76 138.09
Debt/Equity(x) 1.12 0.7 0.53 0.4 0.12 0.14 0.26 0.2 0.12 0.06 0.02
Current Ratio(x) 1.94 2.08 1.66 2.22 2.41 2.48 4.12 3.91 4 3.54 5.37
Quick Ratio(x) 1.25 1.5 1.15 1.55 1.62 1.82 3.27 2.93 3.19 2.6 3.68
Interest Cover(x) 3.96 9.98 12.12 15.06 28.52 48.93 39.62 28.08 27.45 72.14 184.87
Total Debt/Mcap(x) 0 0 0 0 0 0 0.03 0.02 0.01 0 0

Fine Organic Inds. Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 75 75 75 75 75 75 75 75 75 75
FII 7.26 7.25 7.2 6.74 5.91 4.83 3.78 3.78 3.59 4.47
DII 11.21 11.64 10.94 10.92 11.51 12.09 12.24 12.17 11.85 10.76
Public 6.53 6.11 6.86 7.34 7.58 8.08 8.98 9.05 9.57 9.77
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 45% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 33%
  • Debtor days have improved from 39.94 to 34.62days.
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 7 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Fine Organic Inds. News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....